Literature DB >> 9568383

Standardized structure and modular design of a pharmacokinetic database.

F Keller1, T Frankewitsch, D Zellner, S Simon, D Czock, M Giehl.   

Abstract

BACKGROUND: The accumulated knowledge on drugs can be used for an individual drug dosage adjustment if it is placed at our disposal in an informatically structured form. THEORY AND METHODS: We have started building up a pharmacokinetic database aimed at adjusting drug dosages, in exemplary form, to patients with renal impairment. Parameters needed for the three dosage adjustment rules (Dettli, Kunin, Holford) and the most general concept of pharmacokinetics constituted the theoretical basis. TWO PROCESSES PERTAIN TO ALL DRUGS: Distribution and elimination. Total drug clearance and at least two parameters representing distribution and elimination processes are closely interdependent in mathematical terms (clearance = volume of distribution*rate of elimination). This relation yields the unifying concept that serves as a prerequisite for a structured recording of 30 assigned pharmacokinetic and pharmacodynamic parameters within an informatic database. SOLUTIONS AND
RESULTS: The information is retrieved and referenced from 2383 original publications by means of a standardized input module. The complete database at present contains 15,397 records for 1573 drugs. A programmed meta-analytic algorithm is used to calculate the statistical measures for the central value and variance--as available--from the pooled values of primary records. The statistically standardized parameters are extracted for 6601 pharmacokinetic parameters, and placed at the users disposal with the output module. PRACTICAL UTILITY: Following meta-analysis, published pharmacokinetics can be used as statistical estimates of population parameters. The statistical estimates with variances permit an individual drug dosage adjustment by applying the Bayesian approach or neural networks.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568383     DOI: 10.1016/s0169-2607(97)00061-8

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  7 in total

1.  Methodology for the analysis and representation of the medical information about drugs in the Summary of Product Characteristics (SPC).

Authors:  A Venot; C Duclos
Journal:  Proc AMIA Symp       Date:  1999

2.  Building and evaluation of a structured representation of pharmacokinetics information presented in SPCs: from existing conceptual views of pharmacokinetics associated with natural language processing to object-oriented design.

Authors:  Catherine Duclos-Cartolano; Alain Venot
Journal:  J Am Med Inform Assoc       Date:  2003-01-28       Impact factor: 4.497

Review 3.  Fish drug analysis--Phish-Pharm: a searchable database of pharmacokinetics data in fish.

Authors:  Renate Reimschuessel; Leslie Stewart; Elizabeth Squibb; Keiko Hirokawa; Tiffany Brady; Deborah Brooks; Badar Shaikh; Clifford Hodsdon
Journal:  AAPS J       Date:  2005-09-22       Impact factor: 4.009

4.  Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs.

Authors:  David Czock; Frieder Keller; Hanna M Seidling
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

5.  [Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function].

Authors:  Sebastian Maus; Caecilia Holch; David Czock; Florian Thalhammer; Frieder Keller; Bertram Hartmann
Journal:  Wien Klin Wochenschr       Date:  2010-08-04       Impact factor: 1.704

Review 6.  Pharmacokinetic and pharmacodynamic considerations of antimicrobial drug therapy in cancer patients with kidney dysfunction.

Authors:  Frieder Keller; Bernd Schröppel; Ulla Ludwig
Journal:  World J Nephrol       Date:  2015-07-06

Review 7.  Pregnancy and renal failure: the case for application of dosage guidelines.

Authors:  F Keller; M Griesshammer; U Häussler; W Paulus; A Schwarz
Journal:  Drugs       Date:  2001       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.